Drug interactions
Dobutamine + Nateglinide
Severity: Minor
Dobutamine and Nateglinide: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Dobutamine can raise blood glucose through beta-adrenergic stimulation of glycogenolysis and gluconeogenesis, partly offsetting the glucose-lowering effect of nateglinide. Loss of glycemic control is usually modest and manageable during short infusions.
What this interaction means in plain words
Dobutamine and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Dobutamine belongs to Cardiovascular; Nateglinide belongs to Endocrine.
Why it happens
Pharmacodynamic opposition: beta-agonist hyperglycemic effect versus insulin secretagogue action.
What to do
Monitor blood glucose during dobutamine infusion and adjust antidiabetic therapy if hyperglycemia develops.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Dobutamine and Nateglinide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Dobutamine
Other interactions of Nateglinide
- Albiglutide + Nateglinide Moderate
- Alogliptin-metformin + Nateglinide Moderate
- Alogliptin-pioglitazone + Nateglinide Moderate
- Alogliptin + Nateglinide Moderate
- Alpelisib + Nateglinide Moderate
- Amiodarone + Nateglinide Moderate
Frequently asked questions
Can I take Dobutamine with Nateglinide?
MediHelp rates the interaction as minor. Dobutamine and Nateglinide have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Dobutamine can raise blood glucose through beta-adrenergic stimulation of glycogenolysis and gluconeogenesis, partly offsetting the glucose-lowering effect of nateglinide. Loss of glycemic control is usually modest and manageable during short infusions.
How serious is the interaction between Dobutamine and Nateglinide?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose during dobutamine infusion and adjust antidiabetic therapy if hyperglycemia develops.
What other medicines interact with Dobutamine?
MediHelp also lists interactions of Dobutamine with, for example, Budesonide-formoterol, Dihydroergotamine intranasal, Dihydroergotamine. The full list is on the Dobutamine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
